Results of the survey at the CycloLab’s webinar on “Cyclodextrins as active ingredients in the 21st century”
During the webinar of CycloLab “Cyclodextrins as active ingredients in the 21st century” held on Oct. 11, 2021, the participants
A forum for researchers, students and applicants in the field of cyclodextrin technology
During the webinar of CycloLab “Cyclodextrins as active ingredients in the 21st century” held on Oct. 11, 2021, the participants
Alveron Pharma BV (Nijmegen, The Netherlands) has raised a further EUR 3.9 million to fund the continued development of OKL-1111,
The paper Aree [1] starts with an interesting statistics on depression (for the references see the original paper): Depression is
The use of CDs in nasal formulations allowed obtaining versatile drug delivery systems intended for local and systemic effects, as
In this comprehensive review the numerous disadvantages of contact lenses as medicated lenses and the strategies to overcome the same
BioJapan is Asia’s premier hyrid partnering event held on October 13–15, 2021 in Yokohama, Japan. This event is consituted by
The most common method to modify cellular cholesterol content in vitro is to incubate cells with cyclodextrin (CD). However, it
Using MD simulations, the possible role of SBE-β-CDs aggregates in the solubilization of remdesivir was studied. Both the effect of
Inflammation is one of the usual biological responses to different pathologies or stimuli. As the incidence of inflammation related diseases
Cyclodextrin (CD) are classicaly know to be an excellent drug carrier although applications as active drug have been studied (orphan